1112 IMPACT study: can we conduct a trial with a biologic to prevent preeclampsia in women with antiphospholipid syndrome?
Main Authors: | Mimi Kim, Jane E Salmon, Marta Guerra, D Ware Branch |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2021-11-01
|
Series: | Lupus Science and Medicine |
Similar Items
-
1201 IMPACT Study: Preliminary results of a trial with a biologic to prevent preeclampsia in women with antiphospholipid syndrome
by: Mimi Kim, et al.
Published: (2022-12-01) -
Preeclampsia and the Antiphospholipid Syndrome
by: Karoline Mayer-Pickel, et al.
Published: (2023-08-01) -
Adverse pregnancy outcomes in women with systemic lupus erythematosus: can we improve predictions with machine learning?
by: Jane Salmon, et al.
Published: (2022-09-01) -
Laboratory and clinical significance of rare antiphospholipid antibodies in preeclampsia patients : a preliminary study by Mimi Azreen Abdullah
by: Abdullah, Mimi Azreen
Published: (2015) -
Síntesis del 11,12 -DIHIDROXICOUMESTANO
by: Carlos A. Serrano
Published: (1996-03-01)